AAV cGMP Manufacturing

Reliable CDMO services to facilitate gene therapy

Catalog mRNA and LNP

We will assist you from research to clinic!

Lentivirus Packaging Services

Ensuring efficient, effective, safe, and reliable gene delivery

AAV Capsid Engineering

Proven technology paving your path to effective gene therapy

AAV Packaging in World-leading quality

Fast and Effective in as fast as 12-18 business days

CRO
Discovery and Preclinical Services

One-stop Custom AAV Packaging Services

GMP Manufacturing Services

One-stop CDMO Services for GMP Manufacturing

CDMO-Services

Technology Platforms

π-Omega™ Plasmid DNA High-yield Production Platform
π-Omega Plasmid DNA High-yield Production Platform
π-Alpha™ 293 AAV High-yield Production Platform
π-Alpha 293 AAV High-yield Production Platform
π-Icosa™ AAV Serotype Screening Platform

π-Icosa AAV Serotype Screening Platform

Projects Delivery

Clients

GMP Facility

What Customers Are Saying About Us

Leading technology and global reputation

Decibel, Principal Scientist

“A lot of our programs internally have been having great results with the AAV vectors you all have been packaging. PackGene is rapidly becoming our go-to for AAV vectors! ”

Biogen Scientist

“I  have spreaded  the word of my satisfaction with your AAV vectors to many people in  Biogen’s research labs and I hope we continue to be a regular customer in the future.”

Learn More About Us

PACKGENE-NEWS
EVENTS

ASGCT (Maryland, May 4-11, 2024)

Abstract:Welcome to ASGCT 2024, the American Society of Gene and Cell Therapy's flagship conference. Esteemed researchers, clinicians, and industry leaders converge at this influential event to navigate the forefront of gene and cell therapy. In the vibrant atmosphere...

American Academy of Neurology (Colorado, Apri 13-18, 2024)

Abstract:The American Academy of Neurology Conference 2024 in Denver, a pivotal gathering for the brightest minds in neurology. This esteemed event brings together experts, researchers, clinicians, and innovators from around the globe to explore the forefront of...

Advanced Therapies Congress (London, Mar 19-20, 2024)

Abstract:The Advanced Therapies Congress convenes leaders in cell and gene therapy development across diverse sectors: pharma, biotech, startups, researchers, clinicians, academics, HTAs, payers, and regulators. In 2024, our new Gene Editing Track highlights CRISPR...

MDA (Florida, Mar 3-6, 2024)

Abstract:The Muscular Dystrophy Association (MDA) holds the top spot as the leading voluntary health organization in the United States, catering to individuals grappling with muscular dystrophy, ALS, and associated neuromuscular conditions. For over 70 years, MDA has...

Webinar: Quality Delivery of mRNA – LNP with An Unbeatable Timeline

Abstract:Kudo Biotechnology is a global mRNA CDMO company headquartered in Singapore, providing world-class end-to-end cGMP manufacturing solutions for your mRNA needs. Kudo streamlines the manufacturing process of plasmid DNA, mRNA, lipid nanoparticle (LNP) and...

ESGCT 30th ANNUAL CONGRESS BRUSSELS

Time: 24-27 Oct 2023Address: Maison de la Poste, Bruxelles, Brussels, BelgiumContact: Irene Song (Sr. Director, Global Product) irene.song@packgene.comPoster P149:Generation of novel AAV serotype with enhanced infectivity, specificity, and lower toxicity via π-Icosa...

Meeting on the Mesa

Time: Live partnering meetings October 10-12; Virtual partnering meetings October 17-18Address: Park Hyatt Aviara, Carlsbad, CAContact: Luyan He(Head of Commercial Team) Luyan.He@packgene.com

INDUSTRY NEWS

Rare Disease Drug Development Urgently Needs More Funding, Experts Say

Rare diseases currently afflict 300 million people worldwide and 30 million people in the U.S. alone. However, 95% of these diseases lacked an FDA-approved treatment as of January 2023. One reason, industry leaders say, is cost. A 2019 study estimated that orphan drug...

New Anticancer Drug SNB-101 Holds Promise Amidst Legislative Debate

SN Bioscience's pioneering nanoparticle anticancer drug, SNB-101, has sparked hope for patients battling various forms of cancer. Developed from the highly insoluble SN-38 into polymer nanoparticles, SNB-101 has exhibited significant improvements in efficacy and...

How to make mRNA therapeutics safe from the start

The success of mRNA vaccines against COVID-19 has unleashed a flood of interest in using the technology to create more vaccines and treatments for everything from rare diseases and infections to cancer. But before new mRNA therapeutics are put to use, they need to be...

FDA Breaks Records with 2023 Drug Approvals: A Landmark Year in Biotech

In a notable development for biomedical innovation, the United States Food and Drug Administration (FDA) achieved a historic milestone in 2023 by approving a record-breaking 71 new medicines. Among these approvals were several revolutionary treatments, including five...

PackGene’s Newsletter

Receive the latest news and insights to your inbox.